InVivo Biosystems

Our mission is to accelerate deep in-vivo insights into human biology and enable researchers to develop and deliver solutions that improve human health An expert in CRISPR genome editing, InVivo Biosystems creates custom genome-edited C. elegans and zebrafish models to enable aging, developmental and disease studies. Our unique living platforms and technologies bridge the gap between cells and mice, providing faster, cost-effective investigations that focus on proof-of-principle experiments for rapid go/no-go decision making and advance the discovery and early-stage development of new compounds. InVivo Biosystems provides essential services to help pharmaceutical, nutraceutical, biotechnology companies and academic research institutions around the...

Drug discovery,human biology,animal biology,understanding human diseases,and disease modeling

Invivo biosystems operates in the Biotechnology research industry.

Invivo biosystems's revenue is $55.50m

Invivo biosystems has 51 - 200 employees.